Karol Sokolowski1, Hai M Pham1, Eric Wenzler2, Richard A Gemeinhart3,4,5,6. 1. Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois, USA. 2. Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA. wenzler@uic.edu. 3. Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois, USA. rag@uic.edu. 4. Department of Bioengineering, University of Illinois at Chicago, Chicago, Illinois, USA. rag@uic.edu. 5. Department of Chemical Engineering, University of Illinois at Chicago, Chicago, Illinois, USA. rag@uic.edu. 6. Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA. rag@uic.edu.
Abstract
PURPOSE: Skin and soft tissue infections are increasingly prevalent and often complicated by potentially fatal therapeutic hurdles, such as poor drug perfusion and antibiotic resistance. Delivery vehicles capable of versatile loading may improve local bioavailability and minimize systemic toxicities yet such vehicles are not clinically available. Therefore, we aimed to expand upon the use of glutathione-conjugated poly(ethylene glycol) GSH-PEG hydrogels beyond protein delivery and evaluate the ability to deliver traditional therapeutic molecules. METHODS: PEG and GSH-PEG hydrogels were prepared using ultraviolet light (UV)-polymerization. Hydrogel loading and release of selected drug candidates was examined using UV-visible spectrometry. Therapeutic molecules and GST-fusion protein loading was examined using UV-visible and fluorescent spectrometry. Efficacy of released meropenem was assessed against meropenem-sensitive and -resistant P. aeruginosa in an agar diffusion bioassay. RESULTS: For all tested agents, GSH-PEG hydrogels demonstrated time-dependent loading whereas PEG hydrogels did not. GSH-PEG hydrogels released meropenem over 24 h. Co-loading of biologic and traditional therapeutics into a single vehicle was successfully demonstrated. Meropenem-loaded GSH-PEG hydrogels inhibited the growth of meropenem-sensitive and resistant P. aeruginosa isolates. CONCLUSION: GSH ligands within GSH-PEG hydrogels allow loading and effective delivery of charged therapeutic agents, in addition to biologic therapeutics.
PURPOSE: Skin and soft tissue infections are increasingly prevalent and often complicated by potentially fatal therapeutic hurdles, such as poor drug perfusion and antibiotic resistance. Delivery vehicles capable of versatile loading may improve local bioavailability and minimize systemic toxicities yet such vehicles are not clinically available. Therefore, we aimed to expand upon the use of glutathione-conjugated poly(ethylene glycol) GSH-PEG hydrogels beyond protein delivery and evaluate the ability to deliver traditional therapeutic molecules. METHODS: PEG and GSH-PEG hydrogels were prepared using ultraviolet light (UV)-polymerization. Hydrogel loading and release of selected drug candidates was examined using UV-visible spectrometry. Therapeutic molecules and GST-fusion protein loading was examined using UV-visible and fluorescent spectrometry. Efficacy of released meropenem was assessed against meropenem-sensitive and -resistant P. aeruginosa in an agar diffusion bioassay. RESULTS: For all tested agents, GSH-PEG hydrogels demonstrated time-dependent loading whereas PEG hydrogels did not. GSH-PEG hydrogels released meropenem over 24 h. Co-loading of biologic and traditional therapeutics into a single vehicle was successfully demonstrated. Meropenem-loaded GSH-PEG hydrogels inhibited the growth of meropenem-sensitive and resistant P. aeruginosa isolates. CONCLUSION: GSH ligands within GSH-PEG hydrogels allow loading and effective delivery of charged therapeutic agents, in addition to biologic therapeutics.
Authors: Zarchi E Sumon; Charles S Berenson; John A Sellick; Zackery P Bulman; Brian T Tsuji; Kari A Mergenhagen Journal: Infect Dis (Lond) Date: 2019-02-14
Authors: Jason S Buhrman; Laura C Cook; Jamie E Rayahin; Michael J Federle; Richard A Gemeinhart Journal: J Control Release Date: 2013-06-28 Impact factor: 9.776
Authors: Carl T Gustafson; Felix Boakye-Agyeman; Cassandra L Brinkman; Joel M Reid; Robin Patel; Zeljko Bajzer; Mahrokh Dadsetan; Michael J Yaszemski Journal: PLoS One Date: 2016-01-13 Impact factor: 3.240